Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 2,903,139 | 0 | 3,076,220 | 3,141,094 | 2,655,056 |
| Cost of Goods | 713,448 | 0 | 732,060 | 664,625 | 567,519 |
| Gross Profit | 2,189,691 | 0 | 2,344,160 | 2,476,469 | 2,087,528 |
| Operating Expenses | 1,798,378 | 0 | 1,715,060 | 1,613,431 | 1,790,302 |
| Operating Income | 391,761 | 0 | 629,160 | 863,654 | 298,574 |
| Interest Expense | 2,529 | 0 | 7,840 | 8,361 | 5,493 |
| Other Income | 47,007 | 0 | 11,760 | 11,318 | 6,205 |
| Pre-tax Income | 436,239 | 0 | 633,080 | 866,611 | 299,286 |
| Income Tax | 54,027 | 0 | 157,780 | 247,120 | 41,585 |
| Net Income Continuous | 382,212 | 0 | 475,300 | 619,492 | 257,702 |
| Net Income | $382,212 | $0 | $475,300 | $619,501 | $258,522 |
| EPS Basic Total Ops | 0.19 | N/A | 0.22 | 0.29 | 0.13 |
| EPS Basic Continuous Ops | 0.19 | N/A | 0.22 | 0.29 | 0.12 |
| EPS Diluted Total Ops | 0.19 | N/A | 0.22 | 0.29 | 0.12 |
| EPS Diluted Continuous Ops | 0.19 | N/A | 0.22 | 0.29 | 0.12 |
| EBITDA(a) | $535,725 | $0 | $789,251 | $1,012,184 | $437,225 |